Apr. 10 at 1:58 AM
For those wondering what will happen to
$REPL tomorrow (assuming good news), attached is a list of all 51 new (since 1/1/2017) commercial-stage oncology focused bio's share prices 45, 30 & 7 days before & after announcing FDA approval. We also show the bio's share price as of the close on the day before, the "Day Of" in yellow which is the bio's 1st close after announcing FDA approval & the day after.
We exclude
$ONC
You'll note just over half trade higher after FDA approval & just less than half trade lower.
Other oncology focused PDUFA dates nearing;
$ARVN
$NUVL
$CGEM ?
The share prices of those who receive CRLs are not included but even a toddler can guess what happens. All the same we track the data so let us know if you'd like us to share (but we'll tell you they all traded meaningfully lower).
